Pfizer On Track To Acquire Smartphone Cough-Screening Developer ResApp For $74M

Biotech titan Pfizer is using its Australian subsidiary to acquire ResApp Health, the developer of a diagnostic smartphone app known as ResAppDx that uses machine learning algorithms to evaluate the extent of respiratory diseases...